skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
17740877
Filing Dt:
05/10/2022
Publication #:
Pub Dt:
09/01/2022
Inventors:
Zhiwei WANG, Yunhang GUO, Gongyin SHI, Lai WANG
Title:
CRYSTALLINE FORM OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOF
Assignment: 1
Reel/Frame:
059888/0638Recorded: 05/11/2022Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
10/17/2017
Exec Dt:
10/17/2017
Exec Dt:
10/17/2017
Assignee:
MOURANT OZANNES CORPORATE SERVICES (CAYMAN) LIMITED
94 SOLARIS AVENUE, PO BOX 1348
CAMANA BAY, GRAND CAYMAN, CAYMAN ISLANDS KY1-1108
Correspondent:
COOLEY LLP
1299 PENNSYLVANIA AVENUE, N.W.
SUITE 700
WASHINGTON, DC 20004
Assignment: 2
Reel/Frame:
059888/0642Recorded: 05/11/2022Pages: 6
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
11/06/2019
Assignee:
AESCHENGRABEN 27
BASEL, SWITZERLAND 4051
Correspondent:
COOLEY LLP
1299 PENNSYLVANIA AVENUE, N.W.
SUITE 700
WASHINGTON, DC 20004
Assignment: 3
Reel/Frame:
065704/0049Recorded: 11/29/2023Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
01/28/2023
Assignee:
AESCHENGRABEN 27
BASEL, SWITZERLAND 4051
Correspondent:
COOLEY LLP
1299 PENNSYLVANIA AVENUE, N.W.
SUITE 700
WASHINGTON, DC 20004

Search Results as of: 05/09/2024 11:09 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT